FDA Published Report on Public Workshop to Enhance Clinical Study Diversity

https://www.fda.gov/media/179261/download?attachment=&utm_medium=email&utm_source=govdelivery The U.S. Food and Drug Administration is announcing the publication of a report on topics discussed at the 2-day virtual public workshop titled “Public Workshop to Enhance Clinical Study Diversity,” held November 29 and 30, 2023. FDA organized the workshop, in collaboration with the Clinical Trials Transformation Initiative, to discuss strategies to increase broader representation in clinical trials. The report provides a summary of the workshop and does not provide guidance or reflect FDA’s current thinking on this subject. This report also satisfies a Food and Drug Omnibus Reform Act of 2022 mandate to publish a report on the workshop not later than 180 days after the close of the comment period. https://ctti-clinicaltrials.org/virtual-public-workshop-to-enhance-clinical-study-diversity/?utm_medium=email&utm_source=govdelivery